The Chronic Kidney Disease Prognosis Consortium (CKD-PC) was established in 2009 by Kidney Disease: Improving Global Outcomes (KDIGO) (sponsored by the U.S. National Kidney Foundation) to focus on improving the lives of patients with CKD. The CKD-PC now includes data on >30 million participants from >120 cohorts spanning >40 countries, and has provided evidence for a global definition of CKD, the acceptance of new surrogate endpoints in clinical trials, and the establishment of important risk tools for use in clinical care. In this renewal, the CKD-PC will build upon previous successes and continue to respond rapidly to changes in health care guidelines, delivery, and regulation to answer high priority questions facing the global CKD population. 

​To date, the CKD-PC has published over 35 high impact papers with important implications for the definition, staging, and management of CKD.